Clinical Trials
3 trialsNCT00453362 2017-03-31
A Study of Changes in FDG- and FLT-PET Imaging in Patients With Non-Small Cell Lung Cancer Following Treatment With Erlotinib
Genentech, Inc.
Phase 1/2 Completed
NCT00864110 2013-03-22
Pharmacokinetic and Radiation Dosimetry Study Evaluating 99m TC-EC-DG SPECT/CT in Patients With Non-small Cell Lung Cancer (NSCLC)
Cell>Point LLC
Phase 1 Completed
NCT00865319 2013-03-22
Phase 2 Study Comparing 99mTc-EC-DG SPECT/CT With 18F FDG PET/CT in Patients With Non-small Cell Lung Cancer (NSCLC)
Cell>Point LLC
Phase 2 Completed